RouteOne Investments

RouteOne has invested in 1 company and its latest investment was OneSource Specialty Pharma on Mar 18, 2021

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Stelis is an India-based CDMO that provides services such as cGMP manufacturing, process and analytical development for the pharmaceutical sector.
$125M
Mar 18, 2021
-